
The ongoing study of this product started around May 2020. Some results were published earlier this year.
https://ascopubs.org/doi/abs/10.1200/JCO.2022.40.16_suppl.3006
Nov 24, 4:02pm: Will seribantumab receive FDA approval by May 2024? → Will seribantumab receive FDA approval by the end of May 2024?
Close date updated to 2024-05-31 11:59 pm
🏅 Top traders
# | Name | Total profit |
---|---|---|
1 | Ṁ34 | |
2 | Ṁ14 | |
3 | Ṁ12 | |
4 | Ṁ2 | |
5 | Ṁ0 |
People are also trading
@mods very inactive creator, resolves NO. this was basically the latest update i can find: https://www.prnewswire.com/news-releases/elevation-oncology-announces-pipeline-prioritization-realignment-of-resources-to-advance-eo-3021-and-ceo-transition-301715227.html
no headlines about FDA approval, & it seems they had abandoned that timeline/plan a while ago
This market generated zero interest, but for what it's worth, this is now very unlikely to resolve YES.